書誌事項
- タイトル別名
-
- Rechallenge of Everolimus for Metastatic Renal Cell Carcinoma after Recovery from Grade 3 Interstitial Lung Disease : A Case Report
- Grade 3 ノ カンシツセイ ハイ シッカン オ オコシタ テンイセイジンサイボウガン ニ タイシ エベロリムス ノ サイトウヨ オ シコウ シタ 1レイ
この論文をさがす
抄録
We report a case of the rechallenge of everolimus for metastatic renal cell carcinoma (RCC) after successful recovery from grade 3 interstitial lung disease (ILD). A 76-year-old man with metastatic RCC developed grade 3 ILD one month after the initiation of everolimus therapy (10 mg/day). ILD subsided in 4 months after the withdrawal of everolimus and treatment with corticosteroids. Half dose (5 mg/day) of everolimus was rechallenged for 9 months until another grade 3 ILD developed. Everolimus kept the disease under control for 13 months including the discontinuation period.
収録刊行物
-
- 泌尿器科紀要
-
泌尿器科紀要 60 (1), 25-28, 2014-01
泌尿器科紀要刊行会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1050845760713462144
-
- NII論文ID
- 120005385875
-
- NII書誌ID
- AN00208315
-
- ISSN
- 00181994
-
- HANDLE
- 2433/182916
-
- NDL書誌ID
- 025168688
-
- 本文言語コード
- ja
-
- 資料種別
- departmental bulletin paper
-
- データソース種別
-
- IRDB
- NDL
- CiNii Articles